0.6500
0.0000
(0.00%)
At close: April 17 at 4:00:01 PM EDT
0.6825
+0.03
+(5.00%)
After hours: April 17 at 6:06:08 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 5 |
| Avg. Estimate | -0.25 | -0.24 | -0.9 | -0.9 |
| Low Estimate | -0.34 | -0.34 | -1.42 | -1.62 |
| High Estimate | -0.2 | -0.17 | -0.67 | -0.53 |
| Year Ago EPS | -0.45 | -0.41 | -1.7 | -0.9 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 6 |
| Avg. Estimate | -- | -- | -- | 2.08M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 12.5M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.38 | -0.41 | -0.4 | -0.31 |
| EPS Actual | -0.45 | -0.41 | -0.4 | -0.44 |
| Difference | -0.07 | 0 | 0 | -0.13 |
| Surprise % | -17.98% | 1.04% | 1.06% | -43.48% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.25 | -0.24 | -0.9 | -0.9 |
| 7 Days Ago | -0.26 | -0.26 | -1 | -1.07 |
| 30 Days Ago | -0.3 | -0.31 | -1.15 | -1.15 |
| 60 Days Ago | -0.3 | -0.31 | -1.15 | -1.15 |
| 90 Days Ago | -0.3 | -0.31 | -1.15 | -1.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 2 | 3 | 4 | 1 |
| Down Last 7 Days | 1 | 1 | 1 | -- |
| Down Last 30 Days | 1 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VOR | 44.07% | 42.28% | 46.76% | 0.55% |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Reiterates | Oppenheimer: Outperform to Outperform | 3/21/2025 |
| Maintains | Stifel: Buy to Buy | 3/21/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/21/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 12/10/2024 |
| Maintains | Baird: Outperform to Outperform | 11/8/2024 |
Related Tickers
CGEM Cullinan Therapeutics, Inc.
7.89
+3.68%
DSGN Design Therapeutics, Inc.
3.5000
+3.55%
NKTX Nkarta, Inc.
1.8100
+3.43%
ALXO ALX Oncology Holdings Inc.
0.5500
-1.79%
ELEV Elevation Oncology, Inc.
0.3860
+16.72%
PMVP PMV Pharmaceuticals, Inc.
1.0200
+2.00%
BCAB BioAtla, Inc.
0.3238
+2.76%
IMCR Immunocore Holdings plc
28.41
+1.94%
LYEL Lyell Immunopharma, Inc.
0.4336
-1.23%
GBIO Generation Bio Co.
0.3921
+13.03%